Including cyanocobalamin in the injection ensures adequate B12 replacement to prevent neurological complications and megaloblastic anemia that can develop over months of restricted intake
Patent Expirations And Generic Competition Outlook One of the biggest factors influencing the long-term cost of GLP-1 medications is patent protection
At this time, LifeMD provides medication treatment options for both social and performance anxiety, as well as general anxiety and/or depression
The popularity of GLP-1 agonists for diabetes and obesity may lift that therapeutic class toward USD 100 billion within five years, requiring tighter formulary rules and step-therapy edits
In that group, every participant lost at least 5% of body weight
adults meeting the clinical criteria for GLP-1s and monthly costs exceeding $1,000 per user, the financial implications are staggering